Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
0.7369
+0.0488 (7.09%)
At close: May 20, 2025, 4:00 PM
0.7012
-0.0357 (-4.84%)
After-hours: May 20, 2025, 6:59 PM EDT
Palisade Bio Stock Forecast
PALI's stock price has decreased by -88.41% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for Palisade Bio stock ranges from a low of $8.00 to a high of $16. The average analyst price target of $12 forecasts a 1,528.44% increase in the stock price over the next year.
Price Target: $12.00 (+1,528.44%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Palisade Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Brookline Capital | Brookline Capital | Strong Buy Maintains $16 | Strong Buy | Maintains | $16 | +2,071.26% | May 13, 2025 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates $38 | Strong Buy | Initiates | $38 | +5,056.74% | Nov 20, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $23 → $8 | Strong Buy | Maintains | $23 → $8 | +985.63% | Nov 13, 2024 |
| Maxim Group | Maxim Group | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +2,953.33% | May 1, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $23 | Strong Buy | Maintains | $23 | +2,953.33% | Apr 16, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.85
from -10.19
EPS Next Year
-1.07
from -1.85
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.51 | -0.64 | -0.62 | ||
| Avg | -1.85 | -1.07 | -1.06 | ||
| Low | -2.32 | -1.49 | -1.50 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.